Diabetes Treatment: Recent Developments Aristidis VevesDimitrios BaltzisIoanna Eleftheriadou Letter from the Editor Open access 22 November 2013 Pages: 1031 - 1032
“All I want for Christmas is Two”: The Advent of Novel Fixed-Combination Inhalers for COPD and Outlook for 2014 Kai M. Beeh Letter from the Editor Open access 26 November 2013 Pages: 1033 - 1037
2013: The Year of Renal Denervation? Ian B. A. Menown Letter from the Editor Open access 13 December 2013 Pages: 1038 - 1040
Evolution of the Treatment Paradigm for Patients with Metastatic Castration-Resistant Prostate Cancer Zafar MalikHeather PayneAmit Bahl Review 26 November 2013 Pages: 1041 - 1066
The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups David Kountz Review Open access 28 November 2013 Pages: 1067 - 1085
The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension Luis RuilopeAngie Schaefer Original Research Open access 30 November 2013 Pages: 1086 - 1099
The Real-World Dose-Relativity of Sevelamer Hydrochloride and Lanthanum Carbonate Monotherapy in Patients with End-Stage Renal Disease Rosamund J. WilsonMichael S. KeithJ. Brian Copley Original Research 05 December 2013 Pages: 1100 - 1110
Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration Stephen S. JohnstonKathleen WilsonAdam Turpcu Original Research Open access 06 December 2013 Pages: 1111 - 1127
The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy Sarah ThayerWenhui WeiRobert Cuddihy Original Research Open access 30 November 2013 Pages: 1128 - 1140
